Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Capital Employed (2020 - 2025)

AVITA Medical filings provide 6 years of Return on Capital Employed readings, the most recent being 1625.37% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 164692.0% to 1625.37% in Q4 2025 year-over-year; TTM through Dec 2025 was 1625.37%, a 164692.0% increase, with the full-year FY2025 number at 791.4%, down 77422.0% from a year prior.
  • Return on Capital Employed hit 1625.37% in Q4 2025 for AVITA Medical, up from 170.22% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 1625.37% in Q4 2025 to a low of 251.09% in Q2 2025.
  • Median Return on Capital Employed over the past 5 years was 23.59% (2022), compared with a mean of 40.13%.
  • The widest YoY moves for Return on Capital Employed: up 164692bps in 2025, down -18205bps in 2025.
  • AVITA Medical's Return on Capital Employed stood at 19.16% in 2021, then soared by 69bps to 5.86% in 2022, then crashed by -776bps to 51.31% in 2023, then surged by 58bps to 21.55% in 2024, then surged by 7644bps to 1625.37% in 2025.
  • The last three reported values for Return on Capital Employed were 1625.37% (Q4 2025), 170.22% (Q3 2025), and 251.09% (Q2 2025) per Business Quant data.